Browsing Tag
UCLA
5 posts
EMVision (ASX:EMV) ramps up stroke scanner trial with full site activation, algorithm updates, and U.S. expansion
EMVision’s emu scanner trial is gaining momentum across top U.S. and Australian hospitals. Find out how AI upgrades and regional pilots may shape FDA clearance.
MiraDx’s ASTRO 2025 breakthrough: Can PROSTOX ultra finally make radiation therapy safer for prostate cancer patients?
MiraDx’s PROSTOX ultra test at ASTRO 2025 shows high-risk prostate cancer patients can avoid SBRT toxicity with safer regimens. Read the full story.
Winvest Group’s IQI Media strikes strategic deal with BioCalth to power direct-to-consumer health supplement sales
Winvest Group’s IQI Media partners with BioCalth to drive direct-to-consumer health supplement sales with patented calcium L-threonate.
NKGen Biotech administers first dose of troculeucel for FTD under FDA-cleared compassionate use
NKGen Biotech, Inc. (Nasdaq: NKGN), a clinical-stage biotechnology company specializing in natural killer cell therapy, has taken a…
MiraDx to enroll patients for non-tumor based microRNA clinical trial
MicroRNA clinical trial : MiraDx, a Los Angeles-based molecular genetics company, has initiated patient enrollment in collaboration with…